Zevra Therapeutics, Inc. Financial Ratios — ZVRA Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-302.98	-160.06	-23.68	-63.18	-142.59	-131.65	-117.52	-11.87	-21.57	-32.02	-60.21	35.96
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-22.61
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.45
Gross Margin (%)	- -	- -	- -	- -	- -	- -	77.06	90.18	92.81	97.82	92.09	68.59	84.52
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-156.03	-33.93	27.87	-235.78	-176.97	-341.41	-0.17
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-158.4	-35.98	26.98	-245.07	-180.63	-368.47	-3.98
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	81.43	- -	-245.07	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-191.17	-96.28	-29.74	-263.8	-167.69	-381.76	81.41
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-191	-96.03	-29.86	-263.48	-167.69	-446.85	78.17
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-191	-96.03	-29.86	-263.48	-167.69	-446.85	78.17
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.98
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	4	19	22	92	93	82	80	71	2	14	44	60	63
ST Debt	4	1	3	- -	4	4	- -	1	- -	- -	38	- -	- -
LT Debt	- -	18	19	92	90	79	79	70	1	14	6	60	63
Total Debt/EBITDA	-0.85	-1.16	-0.97	-2.68	-2.83	-1.52	-3.97	-15.65	0.2	-0.59	-0.9	-0.75	-353.11
Net Debt/EBITDA	-0.41	-0.53	0.46	-2.17	-2.48	-1.17	-3.7	-14.25	-14.07	2	0.01	-0.32	2.67
Total Debt/EBIT	-0.84	-1.15	-0.96	-2.67	-2.8	-1.51	-3.91	-14.76	0.21	-0.57	-0.88	-0.69	-14.93
Net Debt/EBIT	-0.41	-0.53	0.45	-2.16	-2.45	-1.16	-3.64	-13.43	-14.54	1.93	0.01	-0.3	0.11
EBITDA to Interest Expense	-2.71	-6.02	-4.96	-4.81	-4.5	-7.61	-3.08	-0.64	21.24	-71.52	-32.38	-10.97	-0.02
EBITDA-CapEx/Interest Expense	-2.74	-6.04	-4.99	-4.9	-4.53	-7.61	-3.08	-0.64	20.97	-71.79	-32.57	-10.97	-0.13
EBIT to Interest Expense	-2.75	-6.05	-4.98	-4.84	-4.55	-7.66	-3.12	-0.67	20.56	-74.33	-33.05	-11.84	-0.53
Interest Expense	2	3	5	7	7	7	7	7	- -	- -	2	7	8
Common Equity/Total Assets	-999.07	-365.76	-192.02	-142.94	-314.03	-827	-2,338.57	-2,305.95	-200.86	-306.68	-231.99	-283.67	-148.23
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.97	18.16	8.93	150.95	40.6
Long-Term Debt/Capital (%)	-0.46	-58.04	-22.36	-312.82	-126.27	-56.42	-47.68	-37.07	-0.47	-4.02	-1.55	-13.46	-17.5
Long-Term Debt/Total Assets (%)	3.82	132.08	33.94	108.18	171.5	293.51	754.2	621.45	0.93	11.83	3.2	33.61	22.05
Total Debt/Equity (%)	-16.36	-39.07	-217.03	-492	-162.53	-123.26	-106.81	-106.23	1.27	18.8	70.74	152.01	40.87
Total Debt/Capital (%)	-19.56	-60.73	-26.51	-313.35	-131.22	-58.97	-47.85	-37.54	-0.61	-4.16	-12.29	-13.55	-17.61
Total Debt/Total Assets (%)	163.45	138.2	40.24	108.36	178.21	306.77	756.9	629.38	1.21	12.24	25.4	33.85	22.2
Net Debt to Equity	-7.88	-17.81	102.54	-397.99	-142.33	-94.69	-99.56	-96.71	-88.38	-63.91	-0.46	64.84	-0.31
Net Debt/Capital (%)	-8.59	-20.84	9.01	-161.35	-99.69	-40.01	-43.76	-33.43	29.74	11.85	0.07	-5.37	0.11
EBITDA	-5	-16	-23	-34	-33	-54	-20	-5	8	-24	-49	-81	- -
EBITDA-CapEx	-5	-16	-23	-35	-33	-54	-20	-5	8	-24	-49	-81	-1
Operating Income (Loss)	-5	-16	-23	-34	-33	-54	-20	-5	8	-25	-50	-87	-4

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.38	2.61	6.15	10.2	3.67	1.81	0.59	0.56	26.56	6.89	0.92	2.04	4.86
Current Ratio	0.39	2.61	6.48	11.19	3.99	1.98	1.28	1.11	27.2	7.72	1.18	2.53	5.68
Quick Ratio	0.38	2.61	6.44	10.96	3.85	1.82	0.94	0.9	26.92	7.58	1.15	2.35	5.46
CFO/Avg Current Liab	- -	-3.2	-3.3	-3.97	-3.65	-4.61	-2.72	-0.3	1.77	-2.3	-0.78	-1.29	-0.04
Common Equity/Total Assets	-999.07	-365.76	-192.02	-142.94	-314.03	-827	-2,338.57	-2,305.95	-200.86	-306.68	-231.99	-283.67	-148.23
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.97	18.16	8.93	150.95	40.6
Long-Term Debt/Capital (%)	-0.46	-58.04	-22.36	-312.82	-126.27	-56.42	-47.68	-37.07	-0.47	-4.02	-1.55	-13.46	-17.5
Long-Term Debt/Total Assets (%)	3.82	132.08	33.94	108.18	171.5	293.51	754.2	621.45	0.93	11.83	3.2	33.61	22.05
Total Debt/Equity (%)	-16.36	-39.07	-217.03	-492	-162.53	-123.26	-106.81	-106.23	1.27	18.8	70.74	152.01	40.87
Total Debt/Capital (%)	-19.56	-60.73	-26.51	-313.35	-131.22	-58.97	-47.85	-37.54	-0.61	-4.16	-12.29	-13.55	-17.61
Total Debt/Total Assets (%)	163.45	138.2	40.24	108.36	178.21	306.77	756.9	629.38	1.21	12.24	25.4	33.85	22.2
CFO/Total Liabilities	-16.21	-23.58	-31.32	-28.74	-30.1	-58.09	-27.94	-2.5	179.27	-46.54	-30.36	-50.31	-1.23
CFO/CapEx	-84.84	-312.15	-150.13	-46.3	-182.87	-2,581.1	-912.96	-58.76	102.34	-201.26	-113.29	- -	-1.91
Altman's Z-Score	-22.81	-8.52	-1.71	-2.13	-5.39	-17.54	-37.65	-32.07	25.31	-1.72	-5.65	-7.03	1.27

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	15.28	6.45	14.83	2.36	2.36	2.35	15.33
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	23.89	56.63	24.61	154.57	154.87	155.58	23.8
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.53	8.89
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.47	41.08
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	1.21	1.13	2.44	0.11	0.25	0.69	2.09
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	300.86	323.61	149.79	3,392.69	1,477.97	526.13	174.65
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-276.97	-266.98	-125.19	-3,238.12	-1,323.1	-322.08	-109.77
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	23.89	56.63	24.61	154.57	154.87	107.11	-17.28
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	146	43	59	32	11	45	259	158	232	386	496
- Cash & Cash Equivalents	2	10	32	17	11	18	3	4	112	65	43	34	62
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	19	22	92	93	82	80	71	2	14	44	60	63
Enterprise Value	2	9	117	67	111	92	88	111	149	90	208	377	368
Total Capital	-20	-31	-83	-29	-71	-139	-166	-188	-265	-340	-356	-445	-359
Total Debt/Capital (%)	-19.56	-60.73	-26.51	-313.35	-131.22	-58.97	-47.85	-37.54	-0.61	-4.16	-12.29	-13.55	-17.61
Total Debt / EV	1.98	2.18	0.19	1.37	0.85	0.89	0.91	0.64	0.01	0.16	0.21	0.16	0.17
EV/Sales	- -	- -	- -	- -	- -	- -	6.82	8.35	5.18	8.82	7.58	15.95	3.45
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	18.6	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	19.22	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	21.61	13.73	- -	- -	- -	60.67
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	21.47	13.6	- -	- -	- -	53.33
Diluted Market Cap	- -	- -	146	43	59	32	11	45	259	158	232	386	513
Diluted Enterprise Value	2	9	136	118	142	96	88	111	149	107	233	412	514
EV per Share	4.09	11.31	254.02	73.75	120.76	82.36	47.24	27.86	4.99	2.6	5.87	8.14	6.65
TTM Sales	- -	- -	- -	- -	- -	- -	13	13	29	10	27	24	106
TTM EBITDA	-5	-16	-23	-34	-33	-54	-20	-5	8	-24	-49	-81	- -
TTM Operating Income	-5	-16	-23	-34	-33	-54	-20	-5	8	-25	-50	-87	-4
TTM Cash Flow to Firm	-3	-12	-16	-23	-26	-47	-17	5	11	-18	-32	-61	6
TTM Free Cash Flow to Firm	-3	-12	-16	-22	-26	-47	-17	5	11	-18	-32	-61	7

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-7.27	-1.48	-1.8	-0.59	-0.47	-23.39	24.6	-8.5	-6.99	-5.54	-672.44
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	19.22	- -	- -	- -	- -
Enterprise Value	2	9	117	67	111	92	88	111	149	90	208	377	368
Low Price	- -	- -	174.4	46.4	39.2	27.44	4.24	1.94	5.08	4	3.89	4.2	6.19
EV/Sales	- -	- -	- -	- -	- -	- -	6.82	8.35	5.18	8.82	7.58	15.95	3.45
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	18.6	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.95
Price/Earnings Average	- -	- -	-2.26	-7.41	-1.27	-1.55	-1.65	-2.35	-33.57	-6.98	-3.92	-2.88	5.92
Price/Earnings High	- -	- -	-3.53	-17.46	-1.82	-2.67	-3.45	-6.89	-63.15	-12.15	-5.14	-4.28	8.75
Price/Earnings Low	- -	- -	-1.47	-2.56	-0.83	-0.54	-0.32	-0.6	-17.66	-5.15	-2.99	-1.84	4.11
Price/Book Value	- -	- -	-1.4	-0.35	-0.36	-0.14	-0.05	-0.17	-0.97	-0.45	-0.58	-0.76	-1.17
Price/Book Value Average	- -	- -	-1.18	-1.01	-0.33	-0.4	-0.16	-0.12	-1.08	-0.53	-0.45	-0.6	-1.17
Price/Book Value High	- -	- -	-1.84	-2.38	-0.48	-0.68	-0.34	-0.34	-2.02	-0.92	-0.59	-0.89	-1.72
Price/Book Value Low	- -	- -	-0.77	-0.35	-0.22	-0.14	-0.03	-0.03	-0.57	-0.39	-0.34	-0.38	-0.81
Price/Tangible Book Value	- -	- -	-14.46	-2.3	-1.03	-0.48	-0.15	-0.67	2.04	2.11	-19.25	-11.34	3.45
Price/Tangible Book Value Average	- -	- -	-12.2	-6.55	-0.96	-1.32	-0.54	-0.45	2.26	2.49	-14.94	-8.92	3.43
Price/Tangible Book Value High	- -	- -	-19.04	-15.42	-1.38	-2.26	-1.14	-1.32	4.25	4.33	-19.63	-13.27	5.07
Price/Tangible Book Value Low	- -	- -	-7.94	-2.26	-0.62	-0.46	-0.11	-0.12	1.19	1.84	-11.43	-5.71	2.39
Price/Sales	- -	- -	- -	- -	- -	- -	0.88	3.36	9.05	15.58	8.46	16.34	4.65
Price/Sales Average	- -	- -	- -	- -	- -	- -	3.15	2.26	10.02	18.38	6.57	12.85	4.63
Price/Sales High	- -	- -	- -	- -	- -	- -	6.58	6.61	18.86	32.01	8.62	19.12	6.84
Price/Sales Low	- -	- -	- -	- -	- -	- -	0.61	0.58	5.27	13.58	5.02	8.23	3.22
Price/Cash Flow	- -	- -	-7.22	-1.45	-1.79	-0.59	-0.47	-22.99	24.84	-8.46	-6.92	-5.54	-310.13
Price/Cash Flow Average	- -	- -	-6.09	-4.11	-1.66	-1.62	-1.7	-15.49	27.51	-9.98	-5.38	-4.36	-308.34
Price/Cash Flow High	- -	- -	-9.51	-9.68	-2.39	-2.78	-3.56	-45.33	51.75	-17.38	-7.06	-6.48	-455.5
Price/Cash Flow Low	- -	- -	-3.96	-1.42	-1.08	-0.57	-0.33	-3.97	14.47	-7.37	-4.11	-2.79	-214.25
Price/Free Cash Flow Average	- -	- -	-6.13	-4.2	-1.67	-1.62	-1.7	-15.76	27.25	-10.03	-5.42	-4.36	-668.56
Price/Free Cash Flow High	- -	- -	-9.57	-9.9	-2.4	-2.78	-3.56	-46.12	51.25	-17.46	-7.12	-6.48	-987.65
Price/Free Cash Flow Low	- -	- -	-3.99	-1.45	-1.09	-0.57	-0.33	-4.04	14.33	-7.41	-4.15	-2.79	-464.56
EV/Sales Average	- -	- -	- -	- -	- -	- -	9.09	7.25	6.16	13.33	6.59	13.98	4.64
EV/Sales High	- -	- -	- -	- -	- -	- -	12.53	11.61	14.99	26.95	8.65	20.24	6.84
EV/Sales Low	- -	- -	- -	- -	- -	- -	6.56	5.57	1.41	8.52	5.05	9.35	3.22
EV/EBITDA Average	-0.43	-0.53	-4.98	-5.76	-4.17	-2.8	-5.83	-21.38	22.1	-5.65	-3.72	-4.09	-2,757.12
EV/EBITDA High	-0.43	-0.53	-8.02	-10.6	-4.9	-3.97	-8.03	-34.21	53.78	-11.43	-4.89	-5.93	-4,070.93
EV/EBITDA Low	-0.43	-0.53	-3.08	-3.43	-3.59	-1.75	-4.2	-16.42	5.05	-3.62	-2.85	-2.74	-1,917.19
EV/EBIT Average	-0.42	-0.53	-4.96	-5.73	-4.12	-2.79	-5.74	-20.16	22.83	-5.44	-3.65	-3.79	-116.59
EV/EBIT High	-0.42	-0.53	-7.99	-10.55	-4.85	-3.95	-7.91	-32.26	55.57	-11	-4.79	-5.49	-172.15
EV/EBIT Low	-0.42	-0.53	-3.07	-3.41	-3.55	-1.74	-4.14	-15.49	5.22	-3.48	-2.79	-2.54	-81.07
Last Price	- -	- -	317.76	47.2	64.8	28.48	6.06	11.2	8.71	4.59	6.55	8.34	8.96
High Price	- -	- -	418.4	316	86.4	134.4	45.6	22.08	18.15	9.43	6.68	9.76	13.16
Enterprise Value Average	2	9	113	198	138	151	117	96	176	135	181	330	494
Enterprise Value High	2	9	182	364	162	214	161	154	430	274	238	478	729
Enterprise Value Low	2	9	70	118	119	94	84	74	40	87	139	221	343

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	1	1	1	1	1	2	2	5	35	35	42	54	57
Diluted Weighted Avg Shares	- -	1	- -	1	1	1	2	4	30	34	35	46	57
Basic Weighted Avg Shares	- -	1	- -	1	1	1	2	4	30	34	35	46	55
Revenue per Share	- -	- -	- -	- -	- -	- -	6.93	3.34	0.96	0.29	0.77	0.51	1.92
EBITDA per Share	-9.51	-21.28	-49.35	-37.59	-36.07	-48.14	-10.81	-1.13	0.27	-0.69	-1.37	-1.74	- -
Operating Income per Share	-9.65	-21.38	-49.54	-37.79	-36.43	-48.43	-10.97	-1.2	0.26	-0.72	-1.4	-1.88	-0.08
Basic EPS, GAAP	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.5
Basic EPS from Cont Ops	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.5
Diluted EPS, GAAP	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.45
Diluted EPS from Cont Ops	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.45
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-8.85	-19.07	-44.01	-32.63	-36.14	-48.37	-12.81	-0.49	0.35	-0.54	-0.95	-1.51	-0.03
Free Cash Flow per Basic Share	-8.95	-19.13	-44.3	-33.34	-36.34	-48.39	-12.82	-0.5	0.35	-0.55	-0.95	-1.51	-0.04
Cash & Equivalents per Share	4.03	13.33	111.43	74.28	46.11	19.34	1.74	1.06	3.77	2.4	1.91	1.5	3.45
Book Value per Share	-49.63	-65.21	-227.61	-133	-179.87	-197.38	-132.57	-64.93	-8.97	-10.26	-11.28	-10.92	-7.63
Tangible Book Value per Share	-49.63	-63.06	-21.98	-20.49	-62.8	-59.4	-40.17	-16.68	4.27	2.18	-0.34	-0.74	2.6

Zevra Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)